BESO Biological Research, Inc. is a biotechnology company specializing in the use of fermentation to produce complex nutrients with unique health benefits. BESO Biological Research, Inc. pioneered the role of fermentation produced branched chain fatty acids including 13-Methyltetradecanoic acid, in cancer research. BESO's customized fermentation process produces large colonies of bacteria which generate enzymes that are incubated with soybean medium. This results in the product Q-CAN containing a unique range of nutrients including amino acids, peptides, fatty acids and branched chain fatty acids, as well as soluble vitamins and minerals. BESO has demonstrated in a prospective clinical trial that daily ingestion of Q-CAN can improve the colonic microbiome, and reduce serum cholesterol and inflammatory markers. Additional clinical trials examining the role of Q-CAN in reducing recurrence of prostate cancer and reducing side-effects of cancer management are underway.
21660 copley dr.
Diamond Bar, California 91765
http://www.besocare.com